With GNC shares trading near 52-week and all time lows and the collapse of a planned bond issue the rumors of a sale of the parent company are likely to gather steam in the coming year.
ChromaDex is making progress on a transformation to a finished goods company based on its Niagen ingredient even as it struggles with continuing losses to shareholders.
ChromaDex has reported a rapid rise in sales driven mainly by its Niagen ingredient. But the company continues to post losses, and the stock price has failed to recover from a steep slide more than nine months ago.
Fluctuating sales have pushed ChromaDex Corp. back into the red after a brief flurry operating at a break-even point. CEO Frank Jaksch said the company is on track despite the renewed losses and depressed stock price.
Multilevel marketing company LifeVantage, based in Sandy UT, has been hit with a slew of shareholder lawsuits after saying it had to delay the release of its financial information because of internal accounting flaws.
ChromaDex Corp has been the target of a short seller whose allegations against the company caused the company’s stock price to stagger. CEO Frank Jaksch called the attack ‘baseless.’
Omega-3 supplier Omega Protein has conceded a point in its tussle with an activist investor by agreeing to nominate for a election a board member put forward by the investor, Wynnefield Capital. But the company rejected a call for an abandonment of its...
Dietary supplement heavyweight GNC Holdings has started a review of a wide range of strategic and financial alternatives to increase shareholder value.
MusclePharm Corporation, a sports nutrition firm noted for its aggressive marketing via athlete endorsements, continues its meteoric growth curve even as the company required additional funding earlier this year and the stock price continues to fall.
The management team at supplement manufacturer Nutranomics has turned over in an effort to reinvigorate a company that has lost sales momentum and whose stock price has declined precipitously.
Omega Protein Corporation has received a harsh critique of its diversification strategy from a major investor. Wynnefield Partners filed a Form 13D with the Securities and Exchange Commission calling for the company to seek alternatives—up to and including...
ChromaDex Corp. continued to make progress on its transformation from a company based solely on testing services to a branded ingredient supplier, registering a 182% increase in ingredient sales in its 2014 fiscal year.
Activist investor Bill Ackman has released a new video attack that takes nutritional products network marketing giant Herbalife to task over non-compliant disease treatment claims made for the products on the part of distributors. The company responded...
ChromaDex Corp. further trimmed its loss to 4 cents a share as it continues to capitalize on its Niagen ingredient, the company announced as it reported its final fiscal year 2013 results.
Krill oil producer Neptune Technologies and Bioressources has been slapped with two additional class action shareholders’ rights lawsuits and another two law firms have announced investigations into whether the company has violated securities laws.
Neptune Technologies and Bioressources has been hit with a shareholder rights lawsuit over the Nov. 8 explosion and fire that destroyed the company’s production facility and a resulting steep decline in the company’s share price.
LifeVantage, manufactures of herbal supplement Protandim, recently announced a product recall that reportedly could end up costing the company as much as $7 million before recovery from suppliers.
Zeldes & Haeggquist, a San Diego based shareholders rights law firm, has announced an investigation into possible securities violations by Neptune Technologies & Bioressources following the destruction by fire of the company’s production facilities...
PTeroPure maker ChromaDex is set to raise $10.85m via a sale of common stock that will be used to support its new BluScience retail brand and for general working capital purposes.
US chemical group DuPont has successfully completed its tender offer for Danisco, as 92.2 percent of outstanding shares in the Danish food ingredients firm were tendered by Friday’s deadline, DuPont said on Monday.
The parent company of General Nutrition Centers (GNC) Inc has begun trading on the New York Stock Exchange, joining rival Vitamin Shoppe, which went public in late 2009.
Royal DSM’s acquisition of Martek Biosciences Corporation has moved a step closer to finalisation with the news that its tender offer to buy all of the company’s outstanding shares of common stock at a price of $31.50 (about €24) per share has proved...
Danisco’s executive board and members of its board of directors have accepted DuPont’s offer of DKK 665 per share, corresponding to 28,056 shares with a total value of DKK 18.7m, Danisco said on Wednesday.
Danisco is to be snapped up by DuPont for $6.3bn, in a deal Dupont says could create a global leader in industrial biotech – and help drive science-based solutions to the world’s food and fuel challenges.
Quebec-based Neptune Technologies & Bioressources has announced eight percent growth in revenues to reach $12.7m for its 2010 fiscal year ended February 28, 2010, including $12.6m for its nutraceutical business, despite the temporarily closure its...
Cyanotech has been threatened with being bumped from Nasdaq's
SmallCap market if its share price does not rise above the minimum
$1.00 for 10 consecutive days before the end of May 2006.
Bravo! Foods is planning to increase production capacity of its
fortified flavored milk products - a plan that will be facilitated
by almost $19 million in equity financing.
Three officers of Reliv International have raised the funds they
needed to settle their tax bills by selling a proportion of their
holdings back to the company.
VitaCube has signaled that it sees the future of its food and
beverage portfolio in innovative ingredients, by signing a
strategic license agreement with technology transfer company UTEK,
reports Jess Halliday.
Natural goods company Hain Celestial has reported record sales for
the second quarter 2005, but high costs and charges mean net income
has risen only slightly.
Number one cultures supplier Chr. Hansen is up for sale as its
major stakeholder decides to pull away from the ingredients slice
of the company to focus on the pharmaceutical unit, reports
Lindsey Partos.
Number one cultures supplier Chr. Hansen is up for sale as its
major stakeholder decides to pull away from the ingredients slice
of the company to focus on the pharmaceutical unit. The move will
make the company's still growing...
San Diego-based Alpha Nutraceuticals has bought the business and
assets of Californian supplement maker Avidia Nutritional Group,
boosting its manufacturing capacity to allow for expansion.
Hawaiian firm Cyanotech has yet again managed to stave off a
delisting from the Nasdaq SmallCap market, meeting requirements for
the bid price of $1 per share for a consecutive 10 days in recent
months.
Chromium-based nutritional supplements manufacturer Nutrition 21
announced yesterday it has raised $3.25 million through the
completion of a private placement of 4,062,500 shares of common
stock to be used primarily for the continued...
Maker of dairy alternatives Galaxy Nutritional Foods has entered
into a distribution and licensing agreement with French cheese firm
Fromageries Bel, which will see its products distributed in a large
number of European markets.
Lower sales volumes and higher selling expenses resulted in a drop
in net sales for the first quarter ended 31 March 2003 for US
company Technology Flavors & Fragrances (TFF).
A rights plan offering shareholders the right to increase their
stake in Nutrition 21 has been introduced by the company's
management in a bid to stave off unsolicited or undervalued
takeover bids.
US research and development company Burcon NutraScience has closed
the final tranche of its private placement of 1,8million units,
raising gross proceeds of $3.33 million (€3.53m) to be used in
engineering development and speeding...
